The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. EyePoint Pharmaceuticals Inc shares valued at $673,355 were purchased by ANTHONY P. ADAMIS on Oct 23 ’24. At $10.04 per share, ANTHONY P. ADAMIS acquired 67,100 shares.
Also, David R. Guyer purchased 36,975 shares, netting a total of over 329,817 in proceeds.
Before that, DICICCO WENDY F had added 2,567 shares to its account. In a trade valued at $19,997, the Director bought EyePoint Pharmaceuticals Inc shares for $7.79 each. Upon closing the transaction, the insider’s holdings increased to 2,567 shares, worth approximately $87908.94.
As published in their initiating research note from Citigroup on January 07, 2025, EyePoint Pharmaceuticals Inc [EYPT] has been a Buy and the price target has been revised to $33. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. As of August 28, 2024, Jefferies has initiated its “Buy” rating for EYPT. Earlier on January 22, 2024, JP Morgan initiated its rating. Their recommendation was “an Overweight” for EYPT stock.
Analyzing EYPT Stock Performance
During the last five days, there has been a surge of approximately 14.69%. Over the course of the year, EyePoint Pharmaceuticals Inc shares have jumped approximately 18.39%. Shares of the company reached a 52-week high of $9.50 on 01/07/25 and a 52-week low of $7.15 on 01/17/25. A 50-day SMA is recorded $8.48, while a 200-day SMA reached $10.25. Nevertheless, trading volume fell to 0.55 million shares from 0.98 million shares the previous day.
Support And Resistance Levels for EyePoint Pharmaceuticals Inc (EYPT)
According to the 24-hour chart, there is a support level at 8.43, which, if violated, would cause prices to drop to 8.05. In the upper region, resistance lies at 9.14. The next price resistance is at 9.47. RSI (Relative Strength Index) is 56.92 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.23, which suggests the price will decrease in the coming days. Percent R is at 28.93%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
